|
19 FEBRUARY 2022 |
 |
|
09:00-10:30 |
SESSION 1: CERVICAL PATHOLOGY |
|
|
Presidents: M Kyrgiou, Ε. Paraskevaidis |
|
|
Comments: G. Androutsopoulos, N. Bizzarri, A. Daniilidis |
|
09:00-09:45 |
ASCCP Guidelines on the management of precancerous cervical pathology |
|
|
G. Michail |
|
09:45-10:30 |
ESGO guidelines on the management of cervical cancer |
|
|
A.Papanikolaou |
|
|
|
10:30-13:00 |
SESSION 2: OVARIAN PATHOLOGY |
|
|
Presidents: A. Papanikolaou, N. Vlahos, A. Sioutas |
|
|
Comments: C. Akladios, T. Panoskaltsis |
|
10:30-11:15 |
ESGO guidelines on ovarian cancer |
|
|
I. Zapardiel |
|
11:15-12:00 |
ESGO guidelines on perioperative management of ovarian cancer |
|
|
D. Haidopoulos |
|
12:00-12:30 |
Quality indicators of management in ovarian cancer |
|
|
F. Guyon |
|
12:30-13:00 |
ESGO and SFOG guidelines for management on non-epithelial cancer in adolescent and young adults |
|
|
S. Petousis |
|
|
|
13:00-13:15 |
ΒREAK |
|
|
|
13:15-15:00 |
SESSION 3: ENDOMETRIAL PATHOLOGY |
|
|
Presidents: K. Dinas, G. Grimbizis |
|
|
Comments: F. Guyon, S. Petousis |
|
13:15-14:00 |
Guidelines on the management of endometrial hyperplasia |
|
|
C. Margioula-Siarkou |
|
14:00-15:00 |
ESGO Guidelines on the management of endometrial cancer |
|
|
Prof. N. Concin, ESGO President |
|
|
|
15:00 -15:30 |
ΒREAK |
|
|
|
15:30-17:00 |
SESSION 4: VULVAR PATHOLOGY |
|
|
Presidents: A. Daponte, E. Kontomanolis |
|
|
Comments: N. Thomakos, I. Kalogiannidis, D. Tsolakidis |
|
15:30-16:00 |
Guidelines on the management of precancerous vulvar lesions |
|
|
A. Liberis |
|
16:00-17:00 |
ESGO Guidelines on the management of vulvar cancer |
|
|
Prof. R. Verhaijen |
|
|
|
17:00-17:30 |
SESSION 5: TROPHOBLASTIC DISEASE |
|
|
Presidents: N. Salakos, A. Sioutas |
|
|
Comments: S. Angelidou, A. Samy |
|
17:00-17:30 |
Guidelines on Trophoblastic Disease |
|
|
U. Joneborg |
|
|
|
17:30-19:00 |
SESSION 6: BREAST PATHOLOGY |
|
|
Presidents: M Kalder, G. Dimitrakakis |
|
|
Comments: G-A Spyropoulou, St. Zervoudis |
|
17:30-18:15 |
NCCN guidelines on diagnostic approach of suspect breast lesions |
|
|
K. Dinas |
|
18:15-19:00 |
NCCN guidelines on management of breast cancer |
|
|
M. Κalder |
|
|
|
19:00-19:30 |
SESSION 7: CLOSING REMARKS |
|
|
K. Dinas, A. Papanikolaou. S. Petousis |
|
|
